Rock Springs Capital Management LP 13D and 13G filings for Travere Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-05-15 10:47 am Sale | 2025-03-31 | 13G | TRAVERE THERAPEUTICS INC TVTX | Rock Springs Capital Management LP | 2,921,196 3.300% | -2,052,453 (-41.27%) | Filing |
| 2025-02-14 09:10 am Purchase | 2024-12-31 | 13G | TRAVERE THERAPEUTICS INC TVTX | Rock Springs Capital Management LP | 4,973,649 5.720% | 561,666 (+12.73%) | Filing |
| 2024-05-01 4:11 pm Purchase | 2024-04-25 | 13G | TRAVERE THERAPEUTICS INC TVTX | Rock Springs Capital Management LP | 4,411,983 5.790% | 4,411,983 (New Position) | Filing |